Global PCSK9 Inhibitors Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 161536
- Pages: 150
-
Format:
Summary
The global PCSK9 Inhibitors market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Epatha Evolocumab
Praluent Alirocumab
Bococizumab
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Amgen
Eli Lilly
Sanofi
Pfizer
Novartis
Roche
Merck
Alnylam
AstraZeneca
Affiris
BMS
Ionis Pharmaceuticals
Cyon Therapeutics
Daiichi Sankyo
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Clinical Application
Drug Development
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 PCSK9 Inhibitors of Research
1.1.1 Definition
1.1.2 Specifications of PCSK9 Inhibitors
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Epatha Evolocumab Overview
1.2.1.2 Praluent Alirocumab Overview
1.2.1.3 Bococizumab Overview
1.2.1.4 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Clinical Application
1.3.1.2 Drug Development
1.3.1.3 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Epatha Evolocumab Market Size 2018-2023
3.1.1.1 Global Epatha Evolocumab Market Size and Growth Rate 2018-2023
3.1.1.2 Global Epatha Evolocumab Market Size by Region 2018-2023
3.1.2 Praluent Alirocumab Market Size 2018-2023
3.1.2.1 Global Praluent Alirocumab Market Size and Growth Rate 2018-2023
3.1.2.2 Global Praluent Alirocumab Market Size by Region 2018-2023
3.1.3 Bococizumab Market Size 2018-2023
3.1.3.1 Global Bococizumab Market Size and Growth Rate 2018-2023
3.1.3.2 Global Bococizumab Market Size by Region 2018-2023
3.1.4 Others Market Size 2018-2023
3.1.4.1 Global Others Market Size and Growth Rate 2018-2023
3.1.4.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Epatha Evolocumab Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Epatha Evolocumab Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Epatha Evolocumab Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Praluent Alirocumab Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Praluent Alirocumab Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Praluent Alirocumab Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 Bococizumab Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global Bococizumab Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global Bococizumab Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Others Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Clinical Application Market Size 2018-2023
4.1.1.1 Global Clinical Application Market Size and Growth Rate 2018-2023
4.1.1.2 Global Clinical Application Market Size by Region 2018-2023
4.1.2 Drug Development Market Size 2018-2023
4.1.2.1 Global Drug Development Market Size and Growth Rate 2018-2023
4.1.2.2 Global Drug Development Market Size by Region 2018-2023
4.1.3 Others Market Size 2018-2023
4.1.3.1 Global Others Market Size and Growth Rate 2018-2023
4.1.3.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Clinical Application Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Clinical Application Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Clinical Application Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Drug Development Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Drug Development Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Drug Development Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Others Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global PCSK9 Inhibitors Market Competition
7.1.1 Global PCSK9 Inhibitors Market by Companies
7.1.2 Global PCSK9 Inhibitors Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Amgen
8.1.1 Amgen Company Profile
8.1.2 Amgen Product Portfolio
8.1.3 Amgen Business Performance
8.1.4 Amgen Development Overview
8.2 Eli Lilly
8.2.1 Eli Lilly Company Profile
8.2.2 Eli Lilly Product Portfolio
8.2.3 Eli Lilly Business Performance
8.2.4 Eli Lilly Development Overview
8.3 Sanofi
8.3.1 Sanofi Company Profile
8.3.2 Sanofi Product Portfolio
8.3.3 Sanofi Business Performance
8.3.4 Sanofi Development Overview
8.4 Pfizer
8.4.1 Pfizer Company Profile
8.4.2 Pfizer Product Portfolio
8.4.3 Pfizer Business Performance
8.4.4 Pfizer Development Overview
8.5 Novartis
8.5.1 Novartis Company Profile
8.5.2 Novartis Product Portfolio
8.5.3 Novartis Business Performance
8.5.4 Novartis Development Overview
8.6 Roche
8.6.1 Roche Company Profile
8.6.2 Roche Product Portfolio
8.6.3 Roche Business Performance
8.6.4 Roche Development Overview
8.7 Merck
8.7.1 Merck Company Profile
8.7.2 Merck Product Portfolio
8.7.3 Merck Business Performance
8.7.4 Merck Development Overview
8.8 Alnylam
8.8.1 Alnylam Company Profile
8.8.2 Alnylam Product Portfolio
8.8.3 Alnylam Business Performance
8.8.4 Alnylam Development Overview
8.9 AstraZeneca
8.9.1 AstraZeneca Company Profile
8.9.2 AstraZeneca Product Portfolio
8.9.3 AstraZeneca Business Performance
8.9.4 AstraZeneca Development Overview
8.10 Affiris
8.10.1 Affiris Company Profile
8.10.2 Affiris Product Portfolio
8.10.3 Affiris Business Performance
8.10.4 Affiris Development Overview
8.11 BMS
8.11.1 BMS Company Profile
8.11.2 BMS Product Portfolio
8.11.3 BMS Business Performance
8.11.4 BMS Development Overview
8.12 Ionis Pharmaceuticals
8.12.1 Ionis Pharmaceuticals Company Profile
8.12.2 Ionis Pharmaceuticals Product Portfolio
8.12.3 Ionis Pharmaceuticals Business Performance
8.12.4 Ionis Pharmaceuticals Development Overview
8.13 Cyon Therapeutics
8.13.1 Cyon Therapeutics Company Profile
8.13.2 Cyon Therapeutics Product Portfolio
8.13.3 Cyon Therapeutics Business Performance
8.13.4 Cyon Therapeutics Development Overview
8.14 Daiichi Sankyo
8.14.1 Daiichi Sankyo Company Profile
8.14.2 Daiichi Sankyo Product Portfolio
8.14.3 Daiichi Sankyo Business Performance
8.14.4 Daiichi Sankyo Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
